HKEX Disclosure Requirements for an Applicant's Capital Commitments

Hong Kong’s listing regime has entered a phase where the SFC and HKEX are scrutinising not just historical financials, but forward-looking capital deployment with increasing rigour. Following the HKEX’s December 2024 consultation conclusions on Listing Rule amendments regarding capital market activities (effective 1 January 2025), the Exchange now requires applicants to provide granular, binding disclosure on capital commitments—including firm expenditure plans, contingent liabilities, and the intended use of IPO proceeds—within the prospectus. This shift, codified in HKEX Listing Rules Chapter 11 (Applications) and Chapter 2 (Interpretation), directly addresses past market practices where vague “general working capital” justifications masked undisclosed M&A pipelines or capital-intensive projects. For applicants and their sponsors, the consequence is clear: a prospectus lacking a detailed, board-approved capital commitments schedule risks a negative listing decision or, post-listing, enforcement action under the SFC’s Code of Conduct for Sponsors (paragraph 17.6, 2023 edition). This article dissects the specific disclosure triggers, the mechanics of quantifying contingent commitments under HKFRS/IFRS, and the interplay with the sponsor’s due diligence obligations, drawing on recent HKEX listing decisions and Mayer Brown’s advisory practice.

The Regulatory Trigger: HKEX Listing Rule 11.07 and the 2025 Amendments

The primary source of the enhanced disclosure requirement is HKEX Listing Rule 11.07, which states that an applicant must include in its prospectus “full particulars of the applicant’s capital commitments, including those contracted for but not provided for, and those authorised but not contracted for.” The 2025 amendments, published in the HKEX’s Consultation Conclusions on Proposed Amendments to the Listing Rules Relating to Capital Market Activities (December 2024), expanded this to require a quantified breakdown by maturity—within one year, one to five years, and beyond five years—and a description of the funding source (e.g., IPO proceeds, internal cash, bank facilities).

Contracted vs. Authorised Commitments

The distinction between “contracted for” and “authorised but not contracted for” is material. Contracted commitments are those where the applicant has signed a legally binding agreement—for example, a BVI-incorporated applicant with a PRC operating subsidiary that has entered into a RMB 500 million (approximately HKD 540 million) equipment purchase contract with a third-party supplier. Authorised commitments, by contrast, are those approved by the board but not yet executed, such as a board resolution to acquire a 30% stake in a Cayman-domiciled target for USD 80 million, subject to due diligence. Under the 2025 amendments, both categories must be disclosed in the prospectus, with the board resolution date and the nature of the authorisation clearly stated.

The “General Working Capital” Trap

The HKEX’s Listing Decision LD127-2024 (October 2024) provides a cautionary example. In that case, an applicant for Main Board listing disclosed HKD 1.2 billion of IPO proceeds as “general working capital,” but during the vetting process, the Exchange identified that HKD 800 million was earmarked for a specific capital project—a manufacturing plant expansion in Guangdong. The Exchange required the applicant to reclassify that amount as a “capital commitment” and to provide a detailed project timeline, cost breakdown, and risk analysis (e.g., construction delays, regulatory approvals). The applicant’s sponsor was also required to confirm, under paragraph 17.6 of the SFC’s Code of Conduct for Sponsors, that it had verified the underlying contracts and board minutes. Failure to do so would have resulted in a rejection of the listing application.

Quantifying and Disclosing Contingent Commitments

Contingent capital commitments—those that crystallise upon a future event, such as a performance target or regulatory approval—present a particular challenge. HKEX Listing Rule 11.07, read in conjunction with HKFRS 37 Provisions, Contingent Liabilities and Contingent Assets, requires applicants to disclose the nature, estimated financial effect, and uncertainty surrounding each contingent commitment.

HKFRS 37 and the Prospectus

Under HKFRS 37, a contingent liability is not recognised in the financial statements unless it is probable (more than 50% likelihood) and can be reliably estimated. However, the HKEX’s Guidance Letter HKEX-GL112-24 (June 2024) clarifies that for prospectus disclosure purposes, the threshold is lower: any contingent commitment that is “reasonably possible” (i.e., more than remote) must be disclosed in the “Capital Commitments” note to the accountants’ report and in the “Risk Factors” section of the prospectus. For example, an applicant that has entered into a joint venture agreement (JV) with a PRC state-owned enterprise (SOE) where the JV’s capital injection of RMB 200 million is contingent on the SOE obtaining regulatory approval from the National Development and Reform Commission (NDRC) must disclose this commitment, including the probability of approval and the financial impact if the condition is not met.

The Sponsor’s Due Diligence Obligations

The SFC’s Code of Conduct for Sponsors (2023 edition, paragraph 17.6) imposes a specific duty on the sponsor to “exercise due diligence to verify the accuracy and completeness of the applicant’s disclosure of capital commitments.” This includes:

• Reviewing all material contracts, board minutes, and shareholder resolutions.
• Confirming that the applicant’s board has formally approved all authorised commitments.
• Assessing the applicant’s ability to fund these commitments from its own resources or the IPO proceeds.
• Where the commitment is contingent, evaluating the likelihood of the contingency occurring and the impact on the applicant’s financial position.

In practice, this means the sponsor must obtain a capital commitments schedule from the applicant’s CFO, cross-referenced with the company’s internal budgets and cash flow forecasts. The schedule must be updated as at a date no more than three months before the prospectus is issued, per HKEX Listing Rule 11.10.

Cross-Border Structuring and Jurisdictional Nuances

For applicants with complex cross-border structures—common among PRC-based issuers using a Cayman or BVI holding company—the disclosure of capital commitments must account for the legal and regulatory frameworks of each jurisdiction.

PRC Outbound Investment Regulations

Where the applicant’s capital commitments involve PRC subsidiaries or JV partners, the disclosure must address PRC outbound investment regulations. Under the PRC Foreign Investment Law (effective 1 January 2020) and the NDRC Measures for the Administration of Outbound Investment (2017, as amended), any PRC entity making an outbound investment exceeding USD 300 million must obtain NDRC approval. If the applicant’s commitment is structured as a capital injection from the Hong Kong listing vehicle into a PRC subsidiary, the prospectus must disclose whether this triggers NDRC or MOFCOM filing requirements, and the associated timeline risks.

BVI and Cayman Holding Company Considerations

For BVI or Cayman-incorporated applicants, the capital commitments disclosure must also reference the BVI Business Companies Act (Cap. 285) or the Cayman Islands Companies Act (2023 revision), as applicable. Under Section 58 of the BVI Act, a company’s board must approve any transaction exceeding 5% of the company’s net assets. The prospectus must confirm that such approvals have been obtained for all disclosed capital commitments. In a recent Mayer Brown engagement (2024), a Cayman-incorporated applicant with a BVI subsidiary was required to disclose a board resolution from the BVI subsidiary’s board authorising a USD 50 million capital commitment for a PRC manufacturing facility, as the BVI subsidiary was the contracting entity.

Practical Implications for Applicants and Sponsors

The enhanced disclosure requirements have direct consequences for listing timelines, sponsor work programmes, and post-listing compliance.

Impact on Listing Timelines

Applicants must now prepare a capital commitments schedule at the pre-A1 filing stage (i.e., before submitting the listing application to the HKEX). The schedule must be reviewed by the sponsor and the legal adviser (typically a Hong Kong law firm such as Mayer Brown) at least four weeks before the A1 submission. If the schedule is incomplete or inconsistent with the applicant’s financial statements, the Exchange may issue a deficiency letter under Listing Rule 11.12, delaying the listing process by three to six months.

Sponsor Work Programme Adjustments

The sponsor’s due diligence on capital commitments now requires a dedicated workstream, separate from the financial due diligence on historical results. The sponsor must:

• Conduct interviews with the CFO and heads of business units to identify all material capital commitments.
• Obtain and review all board minutes for the 24 months preceding the listing application.
• Perform a consistency check between the capital commitments schedule and the applicant’s cash flow forecasts, as disclosed in the “Management Discussion and Analysis” (MD&A) section of the prospectus.
• Document the findings in a capital commitments due diligence report, which must be submitted to the Exchange upon request.

Post-Listing Compliance

Once listed, the applicant must continue to disclose material changes to its capital commitments in its annual and interim reports, per HKEX Listing Rules Chapter 13 (Continuing Obligations). Specifically, Rule 13.43 requires a listed issuer to disclose in its annual report “a statement of the issuer’s capital commitments as at the end of the financial year,” with a breakdown by contracted and authorised commitments. Failure to do so can result in a breach of the Listing Rules, leading to a public censure or, in severe cases, suspension of trading.

Actionable Takeaways

1. Prepare a capital commitments schedule at least eight weeks before the A1 filing, cross-referenced with board minutes, signed contracts, and cash flow forecasts, to avoid deficiency letters under Listing Rule 11.12.
2. Disclose all contingent commitments that are “reasonably possible” under HKFRS 37, even if not recognised in the financial statements, to comply with HKEX Guidance Letter GL112-24.
3. Ensure the sponsor conducts a dedicated due diligence workstream on capital commitments, including interviews with the CFO and a consistency check with the MD&A, as required by the SFC Code of Conduct for Sponsors paragraph 17.6.
4. For cross-border structures, address PRC outbound investment regulations (NDRC/MOFCOM) and BVI/Cayman board approval requirements in the prospectus to mitigate jurisdictional risks.
5. Incorporate a post-listing compliance framework that updates capital commitments disclosures in annual and interim reports under Listing Rule 13.43, with quarterly reviews by the company secretary.